Q1 2022 Holdings
Filed 2022-05-16 | 87 holdings | $583.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $145.1M | 5,991,479 | 24.9% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $103.0M | 3,265,101 | 17.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $101.2M | 1,503,929 | 17.4% |
| Alector Inc(ALEC) | COM | 014442107 | $81.8M | 5,738,448 | 14.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $45.8M | 6,340,639 | 7.9% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $39.4M | 125,000 | 6.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $24.0M | 547,453 | 4.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $17.3M | 790,209 | 3.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $17.2M | 895,503 | 3.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $4.9M | 200,000 | 0.8% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $689.0K | 75,000 | 0.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $423.6K | 11,584,280 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $263.4K | 5,183,431 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $198.2K | 3,195,624 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $186.1K | 7,521,024 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $161.7K | 2,069,634 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $158.7K | 3,951,566 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $132.6K | 4,968,756 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $106.7K | 6,638,371 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $97.8K | 2,223,212 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $73.1K | 13,896,543 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $68.6K | 2,291,441 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $64.7K | 1,975,611 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $59.6K | 3,495,943 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $57.6K | 1,646,260 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $51.0K | 2,759,505 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $41.2K | 500,622 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $38.3K | 2,371,445 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $32.5K | 1,274,097 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $31.5K | 1,304,741 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $27.1K | 3,557,507 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $22.9K | 2,359,808 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $21.6K | 951,333 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $20.4K | 1,421,319 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $19.4K | 14,285,714 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $19.2K | 6,117,400 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $18.4K | 325,881 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $18.3K | 3,418,068 | 0.0% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $17.6K | 1,300,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $13.7K | 4,653,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $13.5K | 649,786 | 0.0% |
| Hookipa Pharma Inc | COM | 43906K100 | $11.4K | 5,000,000 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $11.3K | 690,000 | 0.0% |
| Akouos Inc | COM | 00973J101 | $9.4K | 1,975,984 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $9.0K | 381,711 | 0.0% |
| Aligos Therapeutics Inc | COM | 01626L105 | $8.5K | 3,948,360 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $8.3K | 541,108 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $8.0K | 298,597 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.8K | 678,441 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $5.8K | 761,971 | 0.0% |